Boston Common Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$18.7M |
| 2 |
TSMC
TSM
|
+$18.1M |
| 3 |
Edwards Lifesciences
EW
|
+$15.3M |
| 4 |
Conagra Brands
CAG
|
+$14M |
| 5 |
TE Connectivity
TEL
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$12M |
| 2 |
Target
TGT
|
+$10.9M |
| 3 |
KeyCorp
KEY
|
+$10.9M |
| 4 |
Microsoft
MSFT
|
+$9.83M |
| 5 |
Merck
MRK
|
+$8.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.71% |
| 2 | Technology | 8.25% |
| 3 | Financials | 6.09% |
| 4 | Industrials | 4.84% |
| 5 | Consumer Staples | 3.75% |
Similar funds
Boston Common Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Boston Common Asset Management held 359 positions worth $4.81B, up 130% from $2.09B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Common Asset Management deployed $2.61B of net new capital in Q1 2023, opening 101 new positions and adding to 92 existing holdings. Its largest new stake was Edwards Lifesciences: 194,369 shares worth $16.1M.
By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, down from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was PNC Financial Services, an estimated $12M trimmed.
- Boston Common Asset Management's largest Q1 2023 buy was Edwards Lifesciences: 194,369 shares worth $16.1M.
- Boston Common Asset Management added most to AstraZeneca in Q1 2023, an estimated $18.7M increase.
- Boston Common Asset Management's biggest Q1 2023 reduction was PNC Financial Services, cutting an estimated $12M.
- Boston Common Asset Management fully exited Fidelity National Information Services in Q1 2023, selling an estimated $7.82M.
- Boston Common Asset Management's ten largest holdings make up 14% of its $4.81B portfolio in Q1 2023.
- Boston Common Asset Management opened 101 new positions and closed 64 in Q1 2023.
- Boston Common Asset Management's portfolio value rose 130% quarter-over-quarter to $4.81B.
Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.